Regulatory Affairs Service Provider in Turkey
The Turkish Medicines and Medical Devices Agency (TITCK) of the Ministry of Health (MOHAP) is the authoritative body responsible for the regulation, inspection, and control of medicinal products and medical devices. The Registration Regulation of Human Medicinal Products dictates the registration and review procedures for medicinal products and devices intended for human use. Similar to most European and US procedures, the registration of a pharmaceutical product with Turkey’s Ministry of Health requires a license application and a GMP certificate. Regulatory compliance consulting services must also ensure thorough inspection of manufacturing sites to protect patient and employee safety, verifying that manufacturing processes are safe and repeatable. Hence, a GMP certificate is an integral component of the drug manufacturing process. These guidelines set by the Turkish authorities are in line with international standards, with the goal of providing safe and efficient access to medicinal products.
However, obtaining market authorizations for medicinal products takes significantly longer compared to other agencies such as the FDA or EMA . This delay stems from factors such as company response time, committee assessment timeline, and changes in registration regulations resulting in timelines increased by more than 50%. Additionally, Turkey’s nonmembership in the Pharmaceutical Inspection Convention and Cooperation Scheme requires the Turkish authority to negotiate with other countries for mutual recognition of certificates, further contributing to delayed approval processes.
Why choose DDReg as your Regulatory Partner in Turkey?
DDReg’s pharmaceutical regulatory consulting services in Turkey provide ongoing support and development of customized strategies through all regulatory phases. We maintain vigilance on the most recent regulatory requirements to ensure high-quality and timely submissions. We deliver reliable safety measures, ensure risk mitigation, and collaborate with experts to facilitate effortless delivery of product launches, regulatory filings, and market authorizations. DDReg is among the best regulatory affairs services providers in Turkey, and our clients rely on us as a trusted pharma regulatory consulting firm.
Our Regulatory Consulting Services In Turkey Portfolio Covers
- Regulatory Strategies and Expert Views
- Regulatory Due Diligence
- Gap Analysis and Remediation
- New Product Authorizations
- Post Approval Life Cycle Management
- CMC Advisory
- API/DMF
- Regulatory Labelling
- eCTD Publishing and Submission
Our Regulatory Affairs Consulting Services in Turkey portfolio covers:

Regulatory Strategies
The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...

New Product Marketing Authorizations
Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...

Gap Analysis and Remediation
In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...

Regulatory Due Diligence
Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...

API & DMF services
Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...

CMC Advisory
DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...

Post Approval Life Cycle Management
Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...

Certification Services
Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...

ANDA and MA Holder Services
Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.

Publishing & Submission
Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...